MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Sleep disorder Clustering and Clinical Impact in Multiple System Atrophy

    D. Dong, L. Li, L. Luo, W. Wang (Hangzhou, China)

    Objective: To characterize clustering patterns of sleep disorders in multiple system atrophy (MSA) and evaluate their clinical impact. Background: Sleep disorders are common in MSA.…
  • 2026 International Congress

    Mirrored-Self Misidentification Expands the Neuropsychiatric Spectrum of Corticobasal Syndrome

    T. Gonçalves, K. Alves, B. Sampaio, L. Berchielli, R. Pinto, S. Silva (São Paulo, Brazil)

    Objective: To describe mirrored-self misidentification (MSM) occurring in corticobasal syndrome (CBS) without early dementia Background: CBS is a neurodegenerative syndrome characterized by asymmetric parkinsonism and…
  • 2026 International Congress

    “Coder’s Cramp”: A Case Series of Task- Specific Typing Dystonia

    R. Voshtina, S. Barton, J. Ng (Palo Alto, USA)

    Objective: We present a case series of task-specific dystonia that occurs exclusively when typing in three software engineers. Background: Task-specific dystonia refers to abnormal involuntary contraction of muscles only during a particular motor task. Focal hand dystonia related to one’s occupation can…
  • 2026 International Congress

    A Retrospective Study Of Outcomes Of Deep Brain Stimulation In Juvenile Parkinson’s Disease.

    I. Goyal, P M. Wadia, P. Doshi (Mumbai, India)

    Objective: To study the clinical characteristics of patients with JPD who have received DBS with their motor and psycho-social outcomes for a maximum of 5…
  • 2026 International Congress

    Clinical and Multimodal Biomarker Profiles in Progressive Supranuclear Palsy: The PSPNI Cohort Study in China

    Q. Shen, XY. Li, J. Wang, FT. Liu (Shanghai, China)

    Objective: To present an overview of the Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI) from China. Background: Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease…
  • 2026 International Congress

    Prasinezumab’s Impact on Neuromelanin- and Iron-Sensitive MRI Biomarkers in Parkinson’s disease: Findings From the PADOVA Phase IIb Study

    T. Kustermann, š. Holiga, R. Akande, J. Anzures-Cabrera, N. Pross, A. Monnet, T. Nikolcheva, G. Pagano (Basel, Switzerland)

    Objective: To evaluate the effects of prasinezumab on neuroimaging biomarkers in individuals with early-stage Parkinson’s disease (PD) on stable symptomatic medication. Background: PD is characterized by the…
  • 2026 International Congress

    First-in-Human Single-Ascending-Dose Trial of ALN-SNCA, an Intrathecally Administered siRNA for Reducing α-synuclein, in Patients with Early-Stage Parkinson’s Disease

    M. Ahmed, M. Effendi, S. Schneider, M. Rosario, M. Magliocca, A. Gorbenko, B. Bugna, L. Farrelly, P. Kremer, R. Postuma, J. Whitton, A. Avbersek, O. Harari (Tarrytown, USA)

    Objective: Development of a Phase 1, First-in-Human (FIH) clinical trial evaluating ALN-SNCA, a novel, intrathecally (IT) delivered small interfering RNA (siRNA) targeting SNCA mRNA to…
  • 2026 International Congress

    Prevalence and neuroimaging presentations of Parkinsonism patients with p.R544C NOTCH3 mutation in Taiwan

    JJ. Lin (Chu-Shang Jenn, Nantou, Taiwan)

    Objective: To investigate the prevalence and neuroimaging findings of NOTCH3 p.R544C mutation in patients with Parkinsonism in Taiwan. Background: Cerebral autosomal dominant arteriopathy with subcortical…
  • 2026 International Congress

    TRACK-PD: Understanding Treatment Routines and Adherence in Care – Knowledge and Perspective of People Living with Parkinson’s Disease

    D. Marinho, H. C Brigas, G. Harrison-Jones, J. Holenz, F. de Renzis, B. Dias (São Mamede do Coronado, Portugal)

    Objective: TRACK-PD aimed to assess adherence behaviors and drivers of treatment interruption/discontinuation from the patient perspective. Background: Treatment adherence is critical in Parkinson’s disease (PD),…
  • 2026 International Congress

    Clinical Relevance of Oral Health Assessment in Parkinson’s Disease Monitoring

    R. Naqvi, V. Ha, S. Elshourbagy, A. Valverde, S. Tomar, J. Schwartz, A. Naqvi, P. Engen, M. Shaikh, C. Neumann, M. Villanueva, D. Sanchez-Bass, L. Dibenedetto, R. Voigt, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: To evaluate the clinical relevance of oral health assessment in Parkinson’s disease (PD) by determining whether oral inflammatory, microbial, and periodontal alterations are associated…
  • « Previous Page
  • 1
  • …
  • 198
  • 199
  • 200
  • 201
  • 202
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley